- US11597706utility2023Compounds and Compositions for Treating Conditions Associated with NLRP Activity0 cites
- US11596695utility2023Specific Sites for Modifying Antibodies to Make Immunoconjugates0 cites
- US11590158utility2023Pharmaceutical Compositions of Lipoic Acid Choline Ester Salts and Methods of Treatment Using Same0 cites
- US11578053utility2023Chemical Process for Preparing Phenylpiperidinyl Indole Derivatives0 cites
- US11578123utility2023Stable and Soluble Antibodies Inhibiting Tnfα0 cites
- US11566022utility20233-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione Derivatives and Uses Thereof0 cites
- US11554215utility2023Injection Device and Injection Solution Transferring System0 cites
- US11548865utility20232-azaspiro[3.4]octane Derivatives as M4 Agonists0 cites
- US11548897utility2023Crystalline Forms of a Triazolopyrimidine Compound0 cites
- US11541056utility20233-hydroxy-n-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide Derivatives0 cites
- US8344131utility2013Organic Compositions to Treat Beta-enac-related Diseases0 cites
- US8344130utility2013Organic Compositions to Treat Beta-enac-related Diseases0 cites
- US8344129utility2013Organic Compositions to Treat Beta-enac-related Diseases0 cites
- US8344127utility2013Organic Compositions to Treat Beta-enac-related Diseases0 cites
- US8343100utility2013Surgical System Having a Non-invasive Flow Sensor0 cites
- US8344128utility2013Short Interfering Ribonucleic Acid (sirna) for Oral Administration0 cites
- US8344046utility2013Ink Formulations and Uses Thereof0 cites
- US8343966utility2013Organic Compounds0 cites
- US8343918utility2013Stabilized Insulin-like Growth Factor Polypeptides0 cites
- US8343507utility2013Protein from Photobacterium Damselae and Use Thereof0 cites
← PreviousPage 12 of 12